Showing results (901-910 of 1,842) with videos related to

Sort By:
Pageof 185
ESMO Open|December 13, 2021
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyJ Tabernero, L Velez, T L Trevino, et al.
ESMO Open|April 16, 2024
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancerP M Carrera, G Curigliano, D Santini, et al.
ESMO Open|April 14, 2024
A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trialC von Arx, G Della Vittoria Scarpati, L Cannella, et al.
ESMO Open|September 16, 2017
Hallmarks of glioblastoma: a systematic reviewDorte Schou Nørøxe, Hans Skovgaard Poulsen, Ulrik Lassen
ESMO Open|September 2, 2017
Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancerMakoto Nishio, Toyoaki Hida, Shinji Atagi, et al.
ESMO Open|August 2, 2017
Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancerBirgit Gaschler-Markefski, Patricia Sikken, John V Heymach, et al.
ESMO Open|August 2, 2017
Impact of intervention aimed at improving the integration of oncology units and local palliative care services: results of the multicentre prospective sequential MIRTO studyAndrea A Martoni, Barbara Melotti, Claudia Degli Esposti, et al.
ESMO Open|August 2, 2017
Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)Lisa Salvatore, Giuseppe Aprile, Ermenegildo Arnoldi, et al.
ESMO Open|August 2, 2017
Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST studyYasuhiro Hagiwara, Yasuo Ohashi, Takuji Okusaka, et al.
ESMO Open|August 2, 2017
Prevalence of hypothyroidism among patients with breast cancer treated with radiation to the supraclavicular field: a single-centre surveyYuichiro Kikawa, Yasuhiro Kosaka, Kazuki Hashimoto, et al.
Pageof 185